香江聚势，科创出海丨2026产业资本交流会在港成功举办

Core Viewpoint - The event "Linking Global Capital, Driving AI and Technological Innovation Overseas" highlighted the growing synergy between mainland China and Hong Kong in the fields of AI and hard technology, emphasizing the importance of strategic cooperation and capital exchange for the future of technological innovation [4][6]. Group 1: Event Overview - The event was successfully held in Hong Kong, gathering over 40 industry investors, family office representatives, and leaders from tech companies to discuss cutting-edge fields like AI and hard technology [3]. - The event served as a platform for strategic cooperation and showcased the mutual desire to enhance capital exchange between mainland China and Hong Kong [6]. Group 2: Key Insights from Speakers - Zhang Yuhao, CEO of FOFWEEKLY, emphasized the vitality of the markets in both regions and the role of venture capital as a crucial link between national strategy and market dynamism, predicting that investment in China's tech innovation will become a mainstream asset allocation in the next 5-10 years [4]. - Li Haoran, a member of the Hong Kong Legislative Council, pointed out that Hong Kong's advantages as an international capital hub and its legal system can facilitate the "bring in" and "go out" strategies for hard tech companies [7]. Group 3: Future Directions - The Hong Kong government has launched initiatives to support mainland enterprises going overseas, integrating policies and resources to provide one-stop support for businesses [7]. - The event marked the initiation of a long-term strategic platform aimed at establishing stable and efficient communication channels between mainland tech companies looking to expand internationally and global capital [7]. Group 4: Investment Opportunities - The event featured discussions on investment logic in hard technology and cross-border capital collaboration, providing attendees with insights into emerging trends [11]. - A project roadshow showcased high-quality projects from AI, hard technology, and biomedicine, attracting significant interest from investment institutions [11].